Illustration of Cambio Healthcare executives paying Region Dalarna's fines for the Cosmic procurement scandal, with disapproving Konkurrensverket observer.
Àwòrán tí AI ṣe

Cambio to pay Region Dalarna's fines in Cosmic case

Ti AI ṣe iroyin Àwòrán tí AI ṣe

Nine regions, including Region Dalarna, avoid paying 10 million kronor fines each for the illegal procurement of the Cosmic journal system. Supplier Cambio Healthcare will cover the costs per prior agreement. Konkurrensverket criticizes the arrangement but will not act in this case.

Ahmed Elsobky, Chairperson of the Egypt Healthcare Authority, announced a significant surge in Egypt's medical tourism sector, driven by healthcare improvements. The sector generated about $8m in revenue in 2025, treating around 35,000 patients from 124 countries.

Ti AI ṣe iroyin

Only one of 44 motions has been approved in Region Dalarna's council since the election. The motion, by Ulf Berg (M), proposes patients evaluating care via SMS. SVT Nyheter Dalarna has reviewed all motions handled during the mandate period.

Four regional councilors from Samling för Dalarna unveiled plans on Tuesday for a 1.2 billion kronor renovation of Mora lasarett. The investment addresses 1970s operating rooms, work environment issues, and threats of fines following a prolonged process with setbacks.

Ti AI ṣe iroyin

Högskolan Dalarna launches Sweden's first higher education program in assistive technology. Applications open on March 16 and close April 15. The program combines humans, technology, and innovation to enhance independence and quality of life.

Researchers at Uppsala University are launching a new treatment study to help young adults who have had cancer address issues related to sexuality and fertility. Around 40 participants aged 18-39 are involved in a 12-week internet-based program. The study is expected to include a total of about 250 people.

Ti AI ṣe iroyin

Alector, Inc. shares rose following an upgrade by BTIG to Buy from Neutral. The firm expressed increased confidence in the company's pivot to its Alector Brain Carrier platform. Near-term performance will depend on interim data for AL101.

 

 

 

Ojú-ìwé yìí nlo kuki

A nlo kuki fun itupalẹ lati mu ilọsiwaju wa. Ka ìlànà àṣírí wa fun alaye siwaju sii.
Kọ